Close Menu

NEW YORK (360Dx) – BioAffinity Technologies on Wednesday announced it raised more than $4 million in Series A financing.

Company President and CEO Maria Zannes said in a statement that the financing will go toward the commercialization of its lung cancer diagnostic and further development of additional cancer tests and cancer therapeutics.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.